United States · 
Who invested in Cardeas Pharma?
Cardeas Pharma's investors include Novo Holdings, Avalon Ventures and Devon Park BioVentures.
2013
$7.5MSeries A$7.5MGrowth$34MSeries BUnited States · Series B startup
Who invested in Cardeas Pharma
3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Cardeas Pharma and see its new rounds in your feed.Sign up free
Funding summaryUpdated 27 Oct 2026
$49Mraised across 3 rounds since 2012, from 3 sources
$7.5MSeries A$7.5MGrowth$34MSeries B
- Latest round
- Series B, $34MMay 2013
- Step-upi
- 4.5×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $7.5M Mar 2012
- Biggest round
- $34M Series B · May 2013
- Between rounds
- 14 months from the last two
The rounds
- May 2013Series B$34M
No investor was named in the report.
Reported by pevc.dowjones.comSEC filing: $34M sold, first sale May 2013
- Mar 2012Series A$7.5M3 new
From a historical funding recordSEC filing: $7.5M sold, first sale Dec 2011
- Mar 2012Growth$7.5M
No investor was named in the report.
Reported by sec.govSEC filing: $7.5M sold, first sale Dec 2011
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Cardeas Pharma
How much has Cardeas Pharma raised?
Cardeas Pharma has raised $49M across 3 rounds since 2012.
When did Cardeas Pharma last raise?
Cardeas Pharma's most recent round was a Series B of $34M in May 2013.
What was Cardeas Pharma's biggest round?
Its most recent round, $34M in May 2013, is also its largest on record.
Who backed Cardeas Pharma first?
Cardeas Pharma's first round on record, in Mar 2012, was backed by Novo Holdings, Avalon Ventures and Devon Park BioVentures.
What stage is Cardeas Pharma at?
Cardeas Pharma's latest named round is a Series B, in May 2013.
Where is Cardeas Pharma based?
Cardeas Pharma is based in the United States.
Companies like Cardeas Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.